Loading...

We've got a brand new version of Simply Wall St! Try it out

Chemistree Technology

CNSX:CHM
Snowflake Description

Excellent balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CHM
CNSX
€6M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

Chemistree Technology Inc., an investment company, operates in the cannabis sector in the United States and internationally. The last earnings update was 114 days ago. More info.


Add to Portfolio Compare Print
CHM Share Price and Events
7 Day Returns
-4.9%
CNSX:CHM
-0.2%
CA Pharmaceuticals
1.2%
CA Market
1 Year Returns
-70.9%
CNSX:CHM
-45.8%
CA Pharmaceuticals
-0.4%
CA Market
CHM Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Chemistree Technology (CHM) -4.9% -11.4% -35% -70.9% 85.7% 30%
CA Pharmaceuticals -0.2% -1.8% -21.5% -45.8% 251% 334.4%
CA Market 1.2% 3.3% 0.8% -0.4% 7.4% 4.5%
1 Year Return vs Industry and Market
  • CHM underperformed the Pharmaceuticals industry which returned -45.8% over the past year.
  • CHM underperformed the Market in Canada which returned -0.4% over the past year.
Price Volatility
CHM
Industry
5yr Volatility vs Market

Value

 Is Chemistree Technology undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Chemistree Technology. This is due to cash flow or dividend data being unavailable. The share price is CA$0.195.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Chemistree Technology's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Chemistree Technology's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:CHM PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in CAD CA$-0.07
DB:CM1 Share Price ** DB (2019-09-19) in EUR €0.14
DB:CM1 Share Price converted to CAD reporting currency Exchange rate (EUR/ CAD) 1.465 CA$0.21
Canada Pharmaceuticals Industry PE Ratio Median Figure of 13 Publicly-Listed Pharmaceuticals Companies 18.72x
Canada Market PE Ratio Median Figure of 540 Publicly-Listed Companies 14.11x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Chemistree Technology.

CNSX:CHM PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= DB:CM1 Share Price ÷ EPS (both in CAD)

= 0.21 ÷ -0.07

-3.19x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Chemistree Technology is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • Chemistree Technology is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Chemistree Technology's expected growth come at a high price?
Raw Data
CNSX:CHM PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -3.19x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.57x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 0.95x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Chemistree Technology, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Chemistree Technology's assets?
Raw Data
CNSX:CHM PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in CAD CA$0.15
DB:CM1 Share Price * DB (2019-09-19) in EUR €0.14
DB:CM1 Share Price converted to CAD reporting currency Exchange rate (EUR/ CAD) 1.465 CA$0.21
Canada Pharmaceuticals Industry PB Ratio Median Figure of 151 Publicly-Listed Pharmaceuticals Companies 2.32x
Canada Market PB Ratio Median Figure of 2,454 Publicly-Listed Companies 1.44x
CNSX:CHM PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= DB:CM1 Share Price ÷ Book Value per Share (both in CAD)

= 0.21 ÷ 0.15

1.36x

* Primary Listing of Chemistree Technology.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Chemistree Technology is good value based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess Chemistree Technology's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Chemistree Technology has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Chemistree Technology expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Chemistree Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
110.6%
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Chemistree Technology expected to grow at an attractive rate?
  • Unable to compare Chemistree Technology's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Chemistree Technology's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Chemistree Technology's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:CHM Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 110.6%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 58.6%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.8%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:CHM Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:CHM Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-03-31 0 -2 -2
2018-12-31 0 -2 -2
2018-09-30 0 -1 -1
2018-06-30 -1 -1
2018-03-31 0 -1 -1
2017-12-31 0 -1 -1
2017-09-30 -1 -1
2017-06-30 0 -1
2017-03-31 -1 -1
2016-12-31 0 -1
2016-09-30 0 -1
2016-06-30 -1 -1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Chemistree Technology is high growth as no earnings estimate data is available.
  • Unable to determine if Chemistree Technology is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:CHM Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Chemistree Technology Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:CHM Past Financials Data
Date (Data in CAD Millions) EPS *
2019-03-31 -0.07
2018-12-31 -0.06
2018-09-30 -0.05
2018-06-30 -0.04
2018-03-31 -0.03
2017-12-31 -0.04
2017-09-30 -0.05
2017-06-30 -0.06
2017-03-31 -0.10
2016-12-31 -0.14
2016-09-30 -0.15
2016-06-30 -0.14

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Chemistree Technology will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Chemistree Technology's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Chemistree Technology's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  3. Chemistree Technology's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Chemistree Technology's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Chemistree Technology has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Chemistree Technology performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Chemistree Technology's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Chemistree Technology does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Chemistree Technology's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Chemistree Technology's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
Chemistree Technology's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Chemistree Technology Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:CHM Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 0.07 -2.04 1.86
2018-12-31 0.03 -1.79 1.68
2018-09-30 0.04 -1.12 1.06
2018-06-30 -0.74 0.73
2018-03-31 0.05 -0.60 0.63
2017-12-31 0.05 -0.54 0.56
2017-09-30 -0.54 0.51
2017-06-30 -0.52 0.50
2017-03-31 -0.67 0.61
2016-12-31 -0.72 0.66
2016-09-30 -0.71 0.67
2016-06-30 -0.63 0.57
2016-03-31 -0.09 0.43
2015-12-31 -0.07 0.40
2015-09-30 -0.05 0.39
2015-06-30 -0.08 0.43
2015-03-31 -0.55 0.43
2014-12-31 -0.54 0.44
2014-09-30 -0.55 0.44
2014-06-30 -0.55 0.44
2014-03-31 -0.91 0.49
2013-12-31 -0.95 0.53
2013-09-30 -1.00 0.58
2013-06-30 -1.06 0.64
2013-03-31 -0.62 0.70
2012-12-31 -0.73 0.82
2012-09-30 -0.82 0.90

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Chemistree Technology has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Chemistree Technology has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Chemistree Technology improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Chemistree Technology's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Chemistree Technology has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Chemistree Technology's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Chemistree Technology's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Chemistree Technology is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Chemistree Technology's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Chemistree Technology's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Chemistree Technology Company Filings, last reported 5 months ago.

CNSX:CHM Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 5.29 8.17 9.56
2018-12-31 3.86 0.45 0.24
2018-09-30 4.67 0.43 1.96
2018-06-30 3.28 0.42 2.66
2018-03-31 1.10 0.41 1.55
2017-12-31 1.24 0.40 1.64
2017-09-30 -0.02 0.39 0.40
2017-06-30 0.03 0.08 0.14
2017-03-31 0.09 0.00 0.14
2016-12-31 -0.31 0.00 0.02
2016-09-30 -0.17 0.00 0.02
2016-06-30 -0.01 0.00 0.03
2016-03-31 0.06 0.00 0.07
2015-12-31 0.20 0.00 0.22
2015-09-30 0.13 0.00 0.14
2015-06-30 0.20 0.00 0.20
2015-03-31 -0.26 0.00 0.18
2014-12-31 -0.14 0.00 0.20
2014-09-30 -0.02 0.00 0.24
2014-06-30 0.02 0.55 1.10
2014-03-31 -0.60 0.55 0.24
2013-12-31 -0.48 0.55 0.25
2013-09-30 -0.36 0.54 0.27
2013-06-30 -0.25 0.54 0.28
2013-03-31 0.31 0.00 0.36
2012-12-31 0.47 0.00 0.47
2012-09-30 0.64 0.00 0.61
  • Chemistree Technology's level of debt (154.4%) compared to net worth is high (greater than 40%).
  • Chemistree Technology had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Chemistree Technology has sufficient cash runway for 2 years based on current free cash flow.
  • Chemistree Technology has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 92.3% each year.
X
Financial health checks
We assess Chemistree Technology's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Chemistree Technology has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Chemistree Technology's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Chemistree Technology dividends.
If you bought CA$2,000 of Chemistree Technology shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Chemistree Technology's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Chemistree Technology's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:CHM Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Chemistree Technology has not reported any payouts.
  • Unable to verify if Chemistree Technology's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Chemistree Technology's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Chemistree Technology has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Chemistree Technology's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Chemistree Technology afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Chemistree Technology has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Chemistree Technology's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Karl Kottmeier
COMPENSATION CA$60,000
AGE 51
CEO Bio

Mr. Karl Eric Kottmeier serves as the Chief Executive Officer and President of Whattozee Networks Inc. (Former Name: Northrock Resources Inc and Bama Gold Corp.). He has been the President and Chief Executive Officer of Durango Capital Corp. since August 2007. He is the Chief Executive Officer and President of Chemistree Technology Inc. and has been its Director since June 08, 2017. He serves as an Executive Officer of Pemgroup. Mr. Kottmeier served as Chief Executive Officer and President of Avanti Energy Inc. since December 21, 2015 until August 2019. Mr. Kottmeier served as the Chief Executive Officer and President of American Lithium Corp. from August 10, 2016 until February 13, 2017. He served as the Chief Executive Officer and President of Rockridge Capital Corp. since August 29, 2016. Mr. Kottmeier has years of practical experience in listing, financing and administering junior exploration and development companies listed on the TSX and TSX Venture Exchanges. He served as the President of Rockgate Capital Corp., from November 23, 2004 to November 2013 and served as its Chief Executive Officer since November 2013. Mr. Kottmeier served as the President and Chief Executive Officer of Falkirk Resources Corp. since August 2007. He served as a Vice President of Corporation Communications of Sargold Resource Corp. from October 2003 to January 2005. Mr. Kottmeier served as RSP Administrator of Royal Trust since 1992. He served as an Investment Advisor of Leede Financial Markets from 2003 to October 2004. He served as the Chief Executive Officer and President of Jemi Fibre Corp. since June 27, 2013. He served as the Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Secretary and Treasurer of American Paramount Gold Corp. since September 12, 2008. Mr. Kottmeier served as the Chief Executive Officer, President, Chief Financial Officer and Treasurer of Zebra Resources Inc. since September 12, 2008 and its Principal Accounting Officer and Secretary since September 12, 2008. Mr. Kottmeier served as a Director of Finance at UBC Alma Mater Society from 1988 to 1990. He served as an Assistant Director of Finance UBC, AMS from 1987 to 1988. He served as House Manager of Phi Gamma Delta Fraternity from 1987 to 1988. Mr. Kottmeier served at McDermid St. Lawrence Chisholm Securities (now Raymond James Ltd) since 1993 and hired as Broker's Assistant and General Assistant to the Corporate Finance department. Mr. Kottmeier developed personal book of business with over 300 clients focusing on proprietary venture capital underwritings. His corporate Finance experience includes sourcing, research, issue structure, finance, listing and syndication and resigned Corporate Finance position since April 2003. He serves as a Director of Tanqueray Exploration Ltd. He served as Director of Avanti Energy Inc. since May 31, 2013 until August 2019. He served as a Director of Whattozee Networks Inc from March 14, 2008 to December 22, 2014. Mr. Kottmeier served as a Director of American Lithium Corp. from August 10, 2016 until February 13, 2017. Mr. Kottmeier served as a Director of Jemi Fibre Corp. from September 2006 to June 27, 2013. He served as a Director of Falkirk Resources Corp. (Also Known As: Kitsault Resources Ltd.) since September 2006. Mr. Kottmeier served as a Director of Bama Gold Corp. from November 23, 2004 to December 22, 2014. He served as a Director of Rockridge Capital Corp. from January 13, 2007 to August 29, 2016. He served as a Director of Rockgate Capital Corp., since November 23, 2004. Mr. Kottmeier served as a Director of Cornerstone Metals Inc. since April 3, 2009, American Paramount Gold Corp. from July 20, 2006 to December 1, 2008 and Zebra Resources Inc. from July 20, 2006 to December 1, 2008. He served as a Director of Durango Capital Corp., since September 2006. He serves as a Member of Investment Committee at Surge Publishing Ltd. Mr. Kottmeier holds a B.A. in American History from the University of British Columbia.

CEO Compensation
  • Karl's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Karl's remuneration is lower than average for companies of similar size in Canada.
Management Team

Karl Kottmeier

TITLE
CEO, President & Director
COMPENSATION
CA$60K
AGE
51

Doug Ford

TITLE
CFO, Secretary & Director
COMPENSATION
CA$60K
AGE
55

Sheldon Aberman

TITLE
Co-Founder

Kirk Gamley

TITLE
Vice-President of Corporate Development
AGE
46
Board of Directors Tenure

Average tenure of the Chemistree Technology board of directors in years:

1.5
Average Tenure
  • The average tenure for the Chemistree Technology board of directors is less than 3 years, this suggests a new board.
Board of Directors

Karl Kottmeier

TITLE
CEO, President & Director
COMPENSATION
CA$60K
AGE
51
TENURE
2.1 yrs

Doug Ford

TITLE
CFO, Secretary & Director
COMPENSATION
CA$60K
AGE
55
TENURE
11.5 yrs

Sheldon Aberman

TITLE
Co-Founder
TENURE
0.9 yrs

Nicholas Zitelli

TITLE
Director
TENURE
0.4 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Chemistree Technology individual insiders in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
10. Jul 19 Buy Karl Kottmeier Individual 10. Jul 19 10. Jul 19 20,000 CA$0.30 CA$6,000
13. Jun 19 Buy Karl Kottmeier Individual 05. Jun 19 05. Jun 19 50,000 CA$0.45 CA$22,500
05. Feb 19 Buy Sheldon Aberman Individual 31. Jan 19 31. Jan 19 36,447 CA$0.49 CA$17,735
05. Nov 18 Sell Karl Kottmeier Individual 30. Oct 18 30. Oct 18 -150,000 CA$0.35 CA$-52,500
05. Nov 18 Buy Karl Kottmeier Individual 05. Nov 18 05. Nov 18 5,000 CA$0.40 CA$2,000
02. Nov 18 Sell Pacific Equity Management Corp Company 30. Oct 18 30. Oct 18 -246,000 CA$0.35 CA$-86,100
01. Nov 18 Buy Sheldon Aberman Individual 25. Oct 18 25. Oct 18 80,411 CA$0.41 CA$32,578
26. Oct 18 Buy Karl Kottmeier Individual 23. Oct 18 26. Oct 18 72,500 CA$0.50 CA$28,166
X
Management checks
We assess Chemistree Technology's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Chemistree Technology has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Chemistree Technology Inc., an investment company, operates in the cannabis sector in the United States and internationally. The company was formerly known as Whattozee Networks Inc. and changed its name to Chemistree Technology Inc. in August 2017. Chemistree Technology Inc. was incorporated in 2008 and is headquartered in Vancouver, Canada.

Details
Name: Chemistree Technology Inc.
CHM
Exchange: CNSX
Founded: 2008
€8,180,586
37,384,430
Website: http://www.chemistree.ca
Address: Chemistree Technology Inc.
609 Granville Street,
Suite 810,
Vancouver,
British Columbia, V6C 2T4,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
DB CM1 Common Shares Deutsche Boerse AG DE EUR 21. Nov 2008
CNSX CHM Common Shares Canadian National Stock Exchange CA CAD 21. Nov 2008
Number of employees
Current staff
Staff numbers
6
Chemistree Technology employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/20 00:55
End of day share price update: 2019/09/19 00:00
Last earnings filing: 2019/05/29
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.